Trust Company’s HCA Healthcare HCA Stock Holding History

Trust Company’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$780	Hold	2	–	–	﹤0.01%	646
2026 Q1	$946	Hold	2	–	–	﹤0.01%	583
2025 Q4	$934	Buy	+2	New	+$929	﹤0.01%	568

Other funds holding HCA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Trust Company's HCA Position: Q2 2026 in Review

Trust Company held its HCA Healthcare (HCA) position steady in Q2 2026 at 2 shares worth $780. The position accounts for ﹤0.01% of the portfolio, ranked #646.

Trust Company first reported a position in HCA in Q4 2025 and has held it in 3 quarters since. The position peaked at $946 in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

Trust Company held 2 shares of HCA Healthcare worth $780 as of Q2 2026.
Trust Company left its HCA Healthcare share count unchanged in Q2 2026.
HCA Healthcare made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #646 holding.
Trust Company first reported a position in HCA Healthcare in Q4 2025 and has held it in 3 quarters since.
Trust Company's HCA Healthcare position peaked at $946 in Q1 2026.
1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.